Release Date: 22/04/21 09:48 Summary: Financial Review apology to N J (John) Karantzis Price Sensitive: No Download Document 522.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%